Clinical Trial

Evaluation of TMS Visual Outcome

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn if transcranial magnetic stimulation (TMS) can improve the visual outcomes in patients after cataract surgery. The main question it aims to answer is: • Does TMS improve the visual outcome in patients after cataract surgery? Researchers will compare TMS to the sham-controlled treatment (exposure to recorded sounds of pulses without real magnetic stimulation) to see if TMS works to improve the visual outcomes of patients after cataract surgery. Participants will * Undergo TMS treatment or a sham-controlled treatment for consecutive 5 days. * Visit the clinic once every 2 weeks for checkups and tests.
Trial Details
NCT Number NCT06600932
Lead Sponsor Shanghai High Myopia Study Group
Conditions Cataract Surgery Experience
Enrollment 200 participants
Start Date 2024-10
Primary Completion 2025-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2024-09-19